Treatment of fibrin formation with intraocular tissue plasminogen activator

Treatment of fibrin formation with intraocular tissue plasminogen activator - Treatment of fibrin formation with intraocular t-PA

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000006430

Enrollment

Registered

2011-09-28

Start date

2011-11-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patients with intraocular fibrin formation

Interventions

To the case in which intraocular fibrin is formed with the postoperative case or the pathological change in a retinal hemorrhage, steroid medicine and a nonsteroidal anti-inflammatory drug are first p

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: It is considered as the objects of this examination of the case as which the dissolution of fibrin is not regarded under the medical treatment.

Exclusion criteria

Exclusion criteria: The case which has allergy in tPA

Design outcomes

Primary

Measure	Time frame
The evaluation of intraocular fibrin formation at the next day of intraocular injection of tPA	—

Countries

Japan

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026